- Country: South Korea
- Summary: [Academic] Efficacy of Nucleic Acid Drug Candidates for the Development of High -Risk Virus Treatment
- KRT Ref No: 117271636
- Deadline: 14 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 363636364
- Notice Type: Tender
- Document Ref. No.: R25BK00763894-000
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- [Academic] Efficacy of nucleic acid drug candidates for the development of high -risk virus treatment
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN[Academic] Efficacy of Nucleic Acid Drug Candidates for the Development of High -Risk Virus Treatment - Korea Tender
The NATIONAL HEALTH RESEARCH INSTITUTE, a Government sector organization in South Korea, has announced a new tender for [Academic] Efficacy of Nucleic Acid Drug Candidates for the Development of High -Risk Virus Treatment. This tender is published on KoreaTenders under KRT Ref No: 117271636 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-14.
The estimated tender value is KRW 363636364, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
